Guillermo Ruiz-Irastorza

Guillermo Ruiz-Irastorza

UNVERIFIED PROFILE

Are you Guillermo Ruiz-Irastorza?   Register this Author

Register author
Guillermo Ruiz-Irastorza

Guillermo Ruiz-Irastorza

Publications by authors named "Guillermo Ruiz-Irastorza"

Are you Guillermo Ruiz-Irastorza?   Register this Author

94Publications

2687Reads

-Profile Views

Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.

J Rheumatol 2019 May 15;46(5):492-500. Epub 2019 Jan 15.

From the Rheumatology/Division of Neuro and Inflammation Sciences, Department of Clinical and Experimental Medicine, Linköping University, Linköping; Department of Medicine, Unit of Rheumatology, Karolinska Institutet and Karolinska University Hospital, Stockholm; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University, Lund; Unit for Clinical Therapy Research (ClinTRID), Karolinska University, Stockholm, Sweden; Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, Ontario; Division of Rheumatology, Centre Hospitalier Universitaire (CHU) de Québec - Université Laval, Quebec City, Quebec; Division of Rheumatology, Cumming School of Medicine - University of Calgary, Calgary, Alberta; Division of Rheumatology, Department of Medicine, McGill University Health Centre, Montreal, Quebec; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia; Department of Medicine and Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada; Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City, Mexico; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea; Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham; Centre for Rheumatology Research, University College, London; Lupus Research Unit, The Rayne Institute, St. Thomas' Hospital, King's College London School of Medicine, London; Lanarkshire Centre for Rheumatology, Hairmyres Hospital, East Kilbride, Scotland; Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, The University of Manchester and UK National Institute for Health Research (NIHR) Manchester Biomedical Research Centre, Manchester University Foundation Trust, Manchester, UK; Cedars-Sinai/David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, California; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma; Department of Medicine, State University of New York (SUNY) Downstate Medical Center, Brooklyn, New York; Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama; Department of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Feinstein Institute for Medical Research, Manhasset, New York; Division of Rheumatology and Immunology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina; Autoimmunity Institute, Allegheny Health Network, Pittsburgh, Pennsylvania; Northwestern University and Feinberg School of Medicine, Chicago, Illinois; Division of Rheumatology, Emory University School of Medicine, Atlanta, Georgia; University of California San Diego School of Medicine, La Jolla, California; Division of Rheumatology, Medical University of South Carolina, Charleston, South Carolina; Division of Rheumatology, Columbia University Medical Center, New York, New York, USA; Department of Rheumatology, Center for Rheumatology Research Fossvogur Landspitali University Hospital, Reyjkavik, Iceland; Autoimmune Disease Unit, Department of Internal Medicine, Hospital Universitario Cruces, BioCruces Health Research Institute, University of the Basque Country, Barakaldo; Josep Font Autoimmune Diseases Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain; Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; Copenhagen Lupus and Vasculitis Clinic, Centre for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Rheumatology, Kantousspital, Schaffhausen, Switzerland.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.180713
Publisher Site
http://dx.doi.org/10.3899/jrheum.180713DOI Listing
May 2019

Construction of a frailty index as a novel health measure in systemic lupus erythematosus.

J Rheumatol 2019 Apr 15. Epub 2019 Apr 15.

Department of Medicine, Division of Rheumatology, Dalhousie University, Halifax, Nova Scotia, Canada; Department of Community Health & Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada; Division of Geriatric Medicine, Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea;Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; Instituto Nacional de Ciencias Medicas y Nutrición, Mexico City, Mexico; Cedars-Sinai/David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; Divisions of Rheumatology and Clinical Epidemiology, Department of Medicine, McGill University, Montreal, Quebec, Canada; Division of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA; Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY, USA; Division of Rheumatology, CHU de Québec et Université Laval, Quebec City, Canada; Center for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, ON, Canada; Arthritis Research UK Epidemiology Unit, Faculty of Biology Medicine and Health, Manchester Academic Health Sciences Center, The University of Manchester, and NIHR Manchester Musculoskeletal Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Center Manchester, UK; Center for Rheumatology, Department of Medicine, University College London, UK; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Lupus Research Unit, The Rayne Institute, St Thomas' Hospital, King's College London School of Medicine, UK, London, UK; Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, USA; Northwestern University and Feinberg School of Medicine, Chicago, IL, USA; Lupus Center of Excellence, Allegheny Health Network, Pittsburgh, PA, USA; Lanarkshire Center for Rheumatology, Hairmyres Hospital, East Kilbride, Scotland UK; Feinstein Institute for Medical Research, Manhasset, NY, USA; Autoimmune Diseases Research Unit, Department of Internal Medicine, BioCruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Barakaldo, Spain; Emory University School of Medicine, Division of Rheumatology, Atlanta, Georgia, USA Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; Unit for clinical therapy research (ClinTRID), Karolinska Institute, Stockholm, Sweden; Department of Clinical Sciences Lund, Rheumatology, Lund University, Lund, Sweden. Josep Font Autoimmune Diseases Laboratory, IDIBAPS, Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain; Medical University of South Carolina, Charleston, South Carolina, USA; UCSD School of Medicine, La Jolla, CA, USA; Copenhagen Lupus and Vasculitis Clinic, 4242, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; University of Manitoba, Winnipeg, Manitoba, Canada; Hospital for Joint Diseases, NYU, Seligman Center for Advanced Therapeutics, New York NY; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Center and Dalhousie University, Halifax, Nova Scotia, Canada. Funding for this work was provided by the Nova Scotia Health Authority Research Fund. Dr. Sang-Cheol Bae's work was supported in part by NRF-2017M3A9B4050335, Republic of Korea. Dr. Caroline Gordon's work was supported by Lupus UK and the NIHR /Wellcome Trust Clinical Research Facility. The Montreal General Hospital Lupus Clinic is partially supported by the Singer Family Fund for Lupus Research. Dr. Clarke holds The Arthritis Society Chair in Rheumatic Diseases at the University of Calgary. Dr. Paul R. Fortin presently holds a tier 1 Canada Research Chair on Systemic Autoimmune Rheumatic Diseases at Université Laval, and part of this work was done while he was still holding a Distinguished Senior Investigator of The Arthritis Society. Dr. Bruce is a National Institute for Health Research (NIHR) Senior Investigator and is supported by Arthritis Research UK, the NIHR Manchester Biomedical Centre and the NIHR/Wellcome Trust Manchester Clinical Research Facility. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. Dr Isenberg and Dr Rahman are supported by and supported by the National Institute for Health, Research University College London Hospitals Biomedical Research Center. The Hopkins Lupus Cohort is supported by the NIH (grant AR43727 and 69572). Dr. Mary Anne Dooley's work was supported by the NIH (grant RR00046). Dr. Ramsey-Goldman's work was supported by the NIH (grants 5UL1TR001422-02, formerly 8UL1TR000150 and UL-1RR-025741, K24-AR-02318, and P60AR064464 formerly P60-AR- 48098). Dr. Ruiz-Irastorza is supported by the Department of Education, Universities and Research of the Basque Government. Dr. Soren Jacobsen is supported by the Danish Rheumatism Association (A3865) and the Novo Nordisk Foundation (A05990). Dr. John G. Hanly is supported by the Canadian Institutes of Health Research (grant MOP-88526). Address Correspondence to: Dr. John G Hanly, Division of Rheumatology, Nova Scotia Rehabilitation Centre (2nd Floor), 1341 Summer Street, Halifax, Nova Scotia, Canada, B3H 4K4.Email:

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.181338
Publisher Site
http://dx.doi.org/10.3899/jrheum.181338DOI Listing
April 2019

Management of antiphospholipid syndrome.

Ann Rheum Dis 2019 Feb 3;78(2):155-161. Epub 2018 Oct 3.

Department of Rheumatology, Dubai Hospital, Dubai, United Arab Emirates

View Article

Download full-text PDF

Source
http://ard.bmj.com/lookup/doi/10.1136/annrheumdis-2018-21384
Publisher Site
http://dx.doi.org/10.1136/annrheumdis-2018-213846DOI Listing
February 2019

Glucocorticoids and antimalarials in systemic lupus erythematosus: an update and future directions.

Curr Opin Rheumatol 2018 09;30(5):482-489

Autoimmune Diseases Research Unit, Department of Internal Medicine, Biocruces Health Research Institute, Hospital Universitario Cruces, University of The Basque Country, Bizkaia, The Basque Country, Spain.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00002281-900000000-9913
Publisher Site
http://dx.doi.org/10.1097/BOR.0000000000000527DOI Listing
September 2018

Comment on: The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults.

Rheumatology (Oxford) 2018 08;57(8):1501-1502

Autoimmune Diseases Research Unit, Department of Internal Medicine, Biocruces Health Research Institute, Hospital Universitario Cruces, UPV/EHU, Bizkaia, The Basque Country, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/key168DOI Listing
August 2018

Cognitive Impairment in Patients With Neuropsychiatric and Non-neuropsychiatric Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis.

J Int Neuropsychol Soc 2018 Jul 19;24(6):629-639. Epub 2018 Mar 19.

1Department of Neurosciences,School of Medicine and Nursing,University of the Basque Country (UPV/EHU),Leioa,Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S1355617718000073DOI Listing
July 2018

Restrictive Use of Oral Glucocorticoids in Systemic Lupus Erythematosus and Prevention of Damage Without Worsening Long-Term Disease Control: An Observational Study.

Arthritis Care Res (Hoboken) 2018 04 7;70(4):582-591. Epub 2018 Mar 7.

Biocruces Health Research Institute, Hospital Universitario Cruces, University of The Basque Country, Bizkaia, The Basque Country, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.23322DOI Listing
April 2018

Extraparotidal low grade follicular lymphoma associated with primary Sjögren's syndrome.

Med Clin (Barc) 2018 03 1;150(5):204-205. Epub 2017 Sep 1.

Unidad de Enfermedades Autoinmunes, Servicio de Medicina Interna, Hospital Universitario de Cruces, Barakaldo, Bizkaia, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2017.06.056DOI Listing
March 2018

Antiphospholipid syndrome.

Nat Rev Dis Primers 2018 Jan 11;4:17103. Epub 2018 Jan 11.

Thrombosis & Thrombophilia, Guy's and St Thomas' Hospital NHS Foundation Trust, Westminster Bridge Road, London SE1 7EH, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrdp.2017.103DOI Listing
January 2018

Predictors of peripheral arterial disease in SLE change with patient's age.

Lupus Sci Med 2017 12;4(1):e000190. Epub 2017 Jan 12.

Autoimmune Diseases Research Unit, Department of Internal Medicine , Biocruces Health Research Institute, Hospital Universitario Cruces, University of The Basque Country , Bizkaia, The Basque Country , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/lupus-2016-000190DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5255560PMC
January 2017

Prevalence and predictors of valvular heart disease in patients with systemic lupus erythematosus.

Autoimmun Rev 2016 Dec 15;15(12):1134-1140. Epub 2016 Sep 15.

Autoimmune Diseases Research Unit, Department of Internal Medicine, BioCruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Bizkaia, The Basque Country, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.autrev.2016.09.007DOI Listing
December 2016

[Pregnancy in systemic autoimmune diseases: Myths, certainties and doubts].

Med Clin (Barc) 2016 Oct 30;147(7):306-12. Epub 2016 Apr 30.

Lupus Research Unit, St Thomas' Hospital, Londres, Reino Unido.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2016.03.019DOI Listing
October 2016

LDLR and PCSK9 Are Associated with the Presence of Antiphospholipid Antibodies and the Development of Thrombosis in aPLA Carriers.

PLoS One 2016 28;11(1):e0146990. Epub 2016 Jan 28.

Department of Genetics, Physical Anthropology and Animal Physiology, School of Science and Technology, University of the Basque Country (UPV/EHU), Leioa, Spain.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0146990PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731066PMC
July 2016

Rituximab-refractory lupus nephritis successfully treated with belimumab.

Clin Exp Rheumatol 2016 Mar-Apr;34(2):355-6. Epub 2016 Feb 9.

Autoimmune Diseases Research Unit, Department of Internal Medicine, Biocruces Health Research Institute, Hospital Universitario Cruces, University of The Basque Country, Spain.

View Article

Download full-text PDF

Source
July 2016

Systemic lupus erythematosus.

Nat Rev Dis Primers 2016 06 16;2:16039. Epub 2016 Jun 16.

The London Lupus Centre, London Bridge Hospital, London, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nrdp201639
Publisher Site
http://dx.doi.org/10.1038/nrdp.2016.39DOI Listing
June 2016

[Clinical practice guidelines for systemic lupus erythematosus: Recommendations for general clinical management].

Med Clin (Barc) 2016 May 11;146(9):413.e1-14. Epub 2016 Mar 11.

Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Madrid, España; Servicio de Evaluación y Planificación (SESCS), Servicio Canario de la Salud, Santa Cruz de Tenerife, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2016.01.013DOI Listing
May 2016

Prevention of Recurrent Thrombosis in Antiphospholipid Syndrome: Different from the General Population?

Curr Rheumatol Rep 2016 May;18(5):26

Autoimmune Diseases Research Unit, Department of Internal Medicine, BioCruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Bizkaia, The Basque Country, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11926-016-0573-0DOI Listing
May 2016

Effectiveness of Nonpharmacologic Interventions for Decreasing Fatigue in Adults With Systemic Lupus Erythematosus: A Systematic Review.

Arthritis Care Res (Hoboken) 2016 Jan;68(1):141-8

Evaluation Service of the Canary Islands Health Service (SESCS) and Center for Biomedical Research of the Canary Islands (CIBICAN), Canary Islands, Spain, and Spanish Network of Health Services Research for Chronic Diseases (REDISSEC), Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.22675DOI Listing
January 2016

The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment.

Thromb Haemost 2016 Jan 17;115(2):285-90. Epub 2015 Sep 17.

Prof B. J. Hunt, Thrombosis & Haemophilia Centre, St Thomas' Hospital, Westminster Bridge road, London, SE1 7EH, UK, Tel.: +44 2071882736, Fax: +44 2071882717, E-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1160/TH15-06-0491DOI Listing
January 2016

Comparison of high versus low-medium prednisone doses for the treatment of systemic lupus erythematosus patients with high activity at diagnosis.

Autoimmun Rev 2015 Oct 1;14(10):875-9. Epub 2015 Jun 1.

Autoimmune Diseases Research Unit, Department Of Internal Medicine, Biocruces Health Research Institute, Hospital Universitario Cruces, University Of The Basque Country, Bizkaia, The Basque Country, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.autrev.2015.05.011DOI Listing
October 2015

[Metabolic syndrome in patients with systemic lupus erythematosus: causes and consequences].

Med Clin (Barc) 2015 Apr 27;144(7):309-11. Epub 2014 Nov 27.

Unidad de Investigación de Enfermedades Autoinmunes, Servicio de Medicina Interna, Biocruces Health Research Institute, Hospital Universitario de Cruces, Universidad del País Vasco/Euskal Herriko Unibertsitatea, Barakaldo, Bizkaia, España. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00257753140073
Publisher Site
http://dx.doi.org/10.1016/j.medcli.2014.09.011DOI Listing
April 2015

[Rituximab in antiphospholipid syndrome: always, never, sometimes?].

Med Clin (Barc) 2015 Feb 20;144(3):115-7. Epub 2014 Aug 20.

Unidad de Investigación de Enfermedades Autoinmunes, Servicio de Medicina Interna, BioCruces Health Research Institute, Hospital Universitario Cruces, Universidad del País Vasco/Euskal Herriko Unibertsitatea, Barakaldo, Bizkaia, España. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2014.04.014DOI Listing
February 2015

Prevalence and significance of persistently positive antiphospholipid antibodies in women with preeclampsia.

J Rheumatol 2015 Feb 15;42(2):210-3. Epub 2014 Dec 15.

From the Autoimmune Diseases Research Unit, Department of Internal Medicine, and the Department of Obstetrics, BioCruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Universidad del País Vasco (UPV)/ Euskal Herriko Unibertsitatea (EHU), Bizkaia, Spain.C. Gonzalez-Echavarri, MD, Senior Registrar; I. Villar, MD, Consultant Physician; A. Ugarte, MD, Consultant Physician; G. Ruiz-Irastorza, MD, PhD, Professor of Medicine, Head of the Autoimmune Diseases Research Unit, Autoimmune Diseases Research Unit, Department of Internal Medicine, BioCruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, UPV/EHU; R. Larrieta, MD, Consultant Physician, Department of Obstetrics, BioCruces Health Research Institute, Hospital Universitario Cruces.

View Article

Download full-text PDF

Source
http://www.jrheum.org/cgi/doi/10.3899/jrheum.140737
Publisher Site
http://dx.doi.org/10.3899/jrheum.140737DOI Listing
February 2015

Dr. Erdozain, et al reply.

J Rheumatol 2014 Oct;41(10):2086

Autoimmune Diseases Research Unit, Department of Internal Medicine, Biocruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.140442DOI Listing
October 2014

Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus.

Rheumatology (Oxford) 2014 Aug 27;53(8):1470-6. Epub 2014 Mar 27.

Autoimmune Diseases Research Unit, Department of Internal Medicine, Biocruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Bizkaia, The Basque Country, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/keu148DOI Listing
August 2014

Thrombotic antiphospholipid syndrome shows strong haplotypic association with SH2B3-ATXN2 locus.

PLoS One 2013 3;8(7):e67897. Epub 2013 Jul 3.

Department of Genetics, Physical Anthropology and Animal Physiology. School of Science and Technology, University of the Basque Country, UPV/EHU, Leioa, Spain.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0067897PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701057PMC
February 2014

Prednisone in lupus nephritis: how much is enough?

Autoimmun Rev 2014 Feb 2;13(2):206-14. Epub 2013 Nov 2.

Autoimmune Diseases Research Unit, Department of Internal Medicine, Biocruces Health Research Institute, Hospital Universitario Cruces, Spain; University of the Basque Country, Bizkaia, The Basque Country, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.autrev.2013.10.013DOI Listing
February 2014

Peripheral arterial disease in systemic lupus erythematosus: prevalence and risk factors.

J Rheumatol 2014 Feb 15;41(2):310-7. Epub 2014 Jan 15.

From the Autoimmune Diseases Research Unit, Department of Internal Medicine, Biocruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Bizkaia; Department of Internal Medicine, Hospital De Mendaro, Gipuzkoa, The Basque Country, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.130817DOI Listing
February 2014

[Treatment of systemic lupus erythematosus: myths, certainties and doubts].

Med Clin (Barc) 2013 Dec 23;141(12):533-42. Epub 2013 Apr 23.

Unidad de Investigación de Enfermedades Autoinmunes, Servicio de Medicina Interna, Hospital Universitario Cruces, Universidad del País Vasco/Euskal Herriko Unibertsitatea, Barakaldo, Bizkaia, España. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2013.02.014DOI Listing
December 2013

Pulmonary hypertension in systemic lupus erythematosus: prevalence, predictors and diagnostic strategy.

Autoimmun Rev 2013 Jan 25;12(3):410-5. Epub 2012 Jul 25.

Autoimmune Diseases Research Unit, Department of Internal Medicine, Hospital Universitario Cruces, University of the Basque Country, UPV/EHU, Bizkaia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.autrev.2012.07.010DOI Listing
January 2013

Glucocorticoid use and abuse in SLE.

Rheumatology (Oxford) 2012 Jul 23;51(7):1145-53. Epub 2012 Jan 23.

Servicio de Medicina Interna Hospital de Cruces, 48903-Bizkaia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/ker410DOI Listing
July 2012

High intensity anticoagulation in the prevention of the recurrence of arterial thrombosis in antiphospholipid syndrome: 'PROS' and 'CONS'.

Autoimmun Rev 2012 Jun 22;11(8):577-80. Epub 2011 Oct 22.

Clinical Cardiology, Thrombosis Centre, University Hospital, Padova, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.autrev.2011.10.016DOI Listing
June 2012

Intensity and duration of anticoagulation therapy in antiphospholipid syndrome.

Semin Thromb Hemost 2012 Jun 30;38(4):339-47. Epub 2012 Mar 30.

Autoimmune Diseases Research Unit, Service of Internal Medicine, Hospital Universitario Cruces, Bizkaia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0032-1304720DOI Listing
June 2012

Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohorts.

Autoimmun Rev 2012 Mar 18;11(5):357-64. Epub 2011 Oct 18.

Laboratory of Autoimmune Diseases "Josep Font", Department of Autoimmune Diseases, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.autrev.2011.10.009DOI Listing
March 2012

Antiphospohlipid syndrome in obstetrics.

Best Pract Res Clin Obstet Gynaecol 2012 Feb 11;26(1):65-76. Epub 2011 Nov 11.

Autoimmune Diseases Research Unit, Department of Internal Medicine, Hospital Universitario Cruces, University of the Basque Country, Bizkaia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bpobgyn.2011.10.006DOI Listing
February 2012

Lupus and pregnancy: integrating clues from the bench and bedside.

Eur J Clin Invest 2011 Jun 15;41(6):672-8. Epub 2010 Dec 15.

Department Of Internal Medicine, Hospital De Cruces, University Of The Basque Country, Bizkaia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2362.2010.02443.xDOI Listing
June 2011

Antiphospholipid syndrome.

Lancet 2010 Oct 6;376(9751):1498-509. Epub 2010 Sep 6.

Service of Internal Medicine, Hospital de Cruces-University of the Basque Country, Bizkaia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(10)60709-XDOI Listing
October 2010

Predictors of major infections in systemic lupus erythematosus.

Arthritis Res Ther 2009 15;11(4):R109. Epub 2009 Jul 15.

Department of Internal Medicine, Hospital de Cruces, University of the Basque Country, Pza Cruces s/n, Barakaldo, Bizkaia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/ar2764DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745791PMC
December 2009

[The antiphospholipid syndrome in the 21st century].

Med Clin (Barc) 2009 Sep 16;133(10):390-6. Epub 2009 Apr 16.

Hospital de Cruces, Barakaldo, Bizkaia, España.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S002577530800218
Publisher Site
http://dx.doi.org/10.1016/j.medcli.2008.10.046DOI Listing
September 2009

Managing lupus patients during pregnancy.

Best Pract Res Clin Rheumatol 2009 Aug;23(4):575-82

Service and Department of Internal Medicine, Hospital De Cruces, University of the Basque Country, Bizkaia, Spain.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S152169420900045
Publisher Site
http://dx.doi.org/10.1016/j.berh.2009.04.004DOI Listing
August 2009

Gastroesophageal reflux disease.

N Engl J Med 2009 Feb;360(7):729; author reply 729-30

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc082292DOI Listing
February 2009

Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus.

Lupus 2007 ;16(10):810-6

Service of Internal Medicine, Hospital de Cruces, Universidad Del Pais Vasco/Euskal Herriko Unibertsitatea, Bizkaia, The Basque Country, Spain.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/0961203307083316
Publisher Site
http://dx.doi.org/10.1177/0961203307083316DOI Listing
February 2008

A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies.

Arthritis Rheum 2007 Dec;57(8):1487-95

Hospital de Cruces, and University of the Basque Country, Bizkaia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.23109DOI Listing
December 2007

The treatment of antiphospholipid syndrome: a harmonic contrast.

Best Pract Res Clin Rheumatol 2007 Dec;21(6):1079-92

Department of Internal Medicine, Hospital de Cruces, University of the Basque Country, 48903 Barakaldo, Bizkaia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.berh.2007.10.003DOI Listing
December 2007

Antiphospholipid syndrome in pregnancy.

Rheum Dis Clin North Am 2007 May;33(2):287-97, vi

Department of Internal Medicine, Hospital de Cruces, University of the Basque Country, 48903-Bizkaia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rdc.2007.02.003DOI Listing
May 2007

[Not Available].

Reumatol Clin 2007 Mar 13;3(2):90. Epub 2008 Nov 13.

Servicio de Medicina Interna. Hospital de Cruces.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S1699258X0773609
Publisher Site
http://dx.doi.org/10.1016/S1699-258X(07)73609-4DOI Listing
March 2007

Management of thrombosis in antiphospholipid syndrome and systemic lupus erythematosus in pregnancy.

Ann N Y Acad Sci 2005 Jun;1051:606-12

Service and Department of Internal Medicine, Hospital de Cruces, University of the Basque Country, Bizkaia, Spain.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1196/annals.1361.105
Publisher Site
http://dx.doi.org/10.1196/annals.1361.105DOI Listing
June 2005

High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus.

Arch Intern Med 2004 Jan;164(1):77-82

Servicio de Medicina Interna, Hospital de Cruces, Universidad del Pais Vasco/Euskal Herriko Unibertsitatea, Bizkaia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archinte.164.1.77DOI Listing
January 2004

[Plasma homocysteine levels in systemic lupus erythematosus].

Med Clin (Barc) 2003 May;120(18):681-5

Servicio de Medicina Interna. Cátedra de Patología Médica. Universidad del País Vasco/EHU. Barakaldo. Bizkaia. Spain.

View Article

Download full-text PDF

Source
May 2003

Treatment of pregnancy loss in Hughes syndrome: a critical update.

Autoimmun Rev 2002 Oct;1(5):298-304

Lupus Research Unit, The Rayne Institute, St. Thomas' Hospital, London SE1 7EH, UK.

View Article

Download full-text PDF

Source
October 2002

[Hughes syndrome and thrombosis: the debate goes on].

Med Clin (Barc) 2002 Feb;118(3):97-8

View Article

Download full-text PDF

Source
February 2002

Hughes syndrome crosses boundaries.

Autoimmun Rev 2002 Feb;1(1-2):43-8

Lupus Research Unit, The Rayne Institute, St. Thomas' Hospital, London SE1 7EH, UK.

View Article

Download full-text PDF

Source
February 2002